Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development-Reference-Cited by-同舟云学术

Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development

Published:2015-03 Issue:2 Volume:95 Page:95-111
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Moraes Gleiciane Leal,Gomes Guelber Cardoso,Monteiro de Sousa Paulo Robson,Alves Cláudio Nahum,Govender Thavendran,Kruger Hendrik G.,Maguire Glenn E.M.,Lamichhane Gyanu,Lameira Jerônimo

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference120 articles.

1. Global tuberculosis control: WHO report;World Health Organization,2013

2. Cytoplasmic steps of peptidoglycan biosynthesis;Barreteau;FEMS Microbiol Rev,2008

3. ATP-dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation;Basavannacharya;Tuberculosis,2010

4. Essential metabolites of Mycobacterium tuberculosis and their mimics;Lamichhane;mBio,2011

5. Comparison of the UDP-N-acetylmuramate: L-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae;Mahapatra;J Bacteriol,2000

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Identification and Characterization of Drug Targets in Streptococcus pneumoniae ATCC 700669 (Serotype 23F) by Subtractive Genomics;BioMed Research International;2024-01-20

2. Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection;Biomolecules;2023-06-16

3. A pro-oxidant property of vitamin C to overcome the burden of latent Mycobacterium tuberculosis infection: A cross-talk review with Fenton reaction;Frontiers in Cellular and Infection Microbiology;2023-04-19

4. Anti-Tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents;Pharmaceuticals;2023-03-01

5. Myctobacterium tuberculosis DapA as a target for antitubercular drug design;Biotechnology of Microbial Enzymes;2023